Drug use evaluation of cefepime in the first affiliated hospital of Bengbu medical college: A retrospective and prospective analysis

BMC Infectious Diseases

Volumn 13, Issue 1, 2013, Pages

  Qingping, Shi ^a   Feng, Ding ^a   Ran, Sang ^a   Yan, Liu ^a   HaoYu, Yuan ^b   Meiling, Yu ^a  

^a BENGBU MEDICAL COLLEGE   (China)

^b Hegongye 416 Hospital   (China)

Author keywords

Cefepime; Clinical pharmacy; Cost effectiveness; Drug use evaluation

Indexed keywords

CEFEPIME; MACROLIDE; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ADULT; ADVERSE OUTCOME; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM CULTURE; CHINA; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DIARRHEA; DRUG ERUPTION; DRUG INDICATION; DRUG INDUCED HEADACHE; DRUG USE; FEMALE; HUMAN; INFECTION; KIDNEY FUNCTION; LIVER FUNCTION; MAJOR CLINICAL STUDY; MALE; MEDICAL SCHOOL; NAUSEA; PRESCRIPTION; PROSPECTIVE STUDY; RETROSPECTIVE STUDY; TEACHING; TREATMENT DURATION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; ATTITUDE OF HEALTH PERSONNEL; BEHAVIOR THERAPY; CEPHALOSPORINS; CHILD; CHILD, PRESCHOOL; CHINA; COHORT STUDIES; COST-BENEFIT ANALYSIS; DRUG UTILIZATION REVIEW; EDUCATION, MEDICAL; FEMALE; HOSPITALS; HUMANS; INFANT; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 84875684244     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/1471-2334-13-160     Document Type: Article

References (22)

1. Lei J, Wang YS. Cefepime. World Pharm 1996, 17:354-358.
2. Zhang P. New broad-spect rum antibiotics-cefepime. New Drugs Clin Rem (in Chinese) 1995, 14:164-166.
3. Lu HZ, Weng XH, Pang MY. Phase IV trials of cefepime in treat-ment of various moderate or severe bacterial infections. Chin J New Drugs Clin Remedies 2002, 21:268-270.
4. Li SX, Ren B. Clinical application of cefepime. New medicine 2004, 35:49-50.
5. Brodie DC, Smith WE, Hlynka JN. Model for drug usage review in a hospital. Am J Hosp Pharm 1977, 34:251.
6. ASHP ASHP guidelines on the pharmacist's role in drug-use evaluation. Am J Hosp Pharm 1988, 45:385. ASHP.
7. Woods M. Criteria for use of cefepime in adults: American Society of Hospital Pharmacists. Am J Health Syst Pharm 1994, 51:531.
8. World Health Organization Introduction to drug utilization research 2003, 1-84. Norway: Printed in Oslo, World Health Organization.
9. Bae JP. Project Officer Health Care Financing Administration Office of Research and Demonstrations. Evaluation of Drug Use Review Demonstration Projects, Project Officer Health Care Financing Administration Office of Research and Demonstrations 1998, 1-376. HCFA Evaluation of Drug Review Projects-Final report, http://www.abtassociates.com/reports/19986221703451.pdf.
10. Wu TC, Fu Y. Brief introduction of drug use evaluation. Chin J Pharmaco Epidemiol 2005, 14:46-49.
11. Thomas M, Alexander B, Tony S. Guidlines for implementing for drug utilization review programs in hospitals 1997, 1-59. Rational Pharmaceutical Management Project, http://dmsic.moph.go.th/download/DUR_guidelines.pdf.
12. Ministry of Health of the People's Republic of China, The State Administration of Traditional Chinese Medicine, The Health Bureau The clinical application of antibacterial drugs guiding principles 2004, http://www.sda.gov.cn/WS01/CL0056/10752.html, Ministry of Health of the People's Republic of China, The State Administration of Traditional Chinese Medicine, The Health Bureau.
13. Raveh D, Muallem-zilcha E, Greenberg A. Prospective drug utilization evaluation of threebroad-spectrum antimicrobials: cefepime, piperacillin-tazobactam and meropenem. Q J Med 2006, 99:397-406.
14. Ma Y, Li JY, Hu CQ. Study on the antimicrobial activities of cefepime against gram-negative bacteria in vitro from 1999 to 2002 in China. Chin J Lab Med 2004, 27:747-751.
15. Nasir Tajure W, Oumer S. Drug use evaluation of ciprofloxacin in teriary settding hospital. J Med Pharm Sci 2011, 1:17-23.
16. Wasam Liaqat T, Mehreen F, Fatima A. Drug Utilization Evaluation of vancomycin in Teaching Hospitals of Lahore. J Pharm Sci Res 2012, 4:1728-1733.
17. Wang HL, Ma LJ, Liu XW. Drug Resistance the Fourth Generation Cephalosporin Cefepime and Its Risk Factors. Evaluation Analysis Drug-use Hospitals Chin 2010, 10:1092-1094.
18. Yinnon AM. Whither infectious diseases consultations. Analysis of 14,005 consultations from a 5-year period. Clin Infect Dis 2001, 33:1661-1667. 10.1086/323760, 11595982.
19. Wang Q, Liu YP, Han Q. The ADR review of cefepime. Tianjin Pharmacy 2009, 21:52-55.
20. Jin SP, Li CJ. Drug adverse reaction of cefepime. Chin J Misdiagn 2009, 9:7039-7040.
21. Navarro R. Drug Utilization Review Strategies. Managed Care Pharm Prac 2008, 8:215-229.
22. Bailey TC, Troy McMullin S. Using information systems technology to improve antibiotic prescribing. Crit Care Med 2001, 29:87-91.